• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于逻辑回归森林图探索完成门诊治疗的利福平敏感型肺结核患者空洞持续存在的影响因素。

Exploring the influencing factors of cavities persist in rifampicin-sensitive pulmonary tuberculosis patients who have completed outpatient treatment based on logistic regression forest plot.

作者信息

Li Shan, Luo Shui-Rong, Feng Yin-Ping, Xu Bi-Qing

机构信息

Department of Tuberculosis, Lishui Hospital of Traditional Chinese Medicine Affiliated to Zhejiang University of Traditional Chinese Medicine, Lishui Tuberculosis Clinical Medical Research Center, Lishui, Zhejiang, China.

出版信息

Medicine (Baltimore). 2025 Jun 27;104(26):e43089. doi: 10.1097/MD.0000000000043089.

DOI:10.1097/MD.0000000000043089
PMID:40587703
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12212854/
Abstract

This study explores the factors influencing the persistence of cavities in patients with rifampicin-sensitive pulmonary tuberculosis who have completed outpatient follow-up treatment based on multiple regression analysis. A total of 218 rifampicin-sensitive pulmonary tuberculosis patients with pulmonary cavities, who were followed up at our hospital from January 2022 to October 2023, were selected as the study subjects. General patient data were collected, including gender, age, residence, smoking status, hemoptysis symptoms, presence of diabetes, initial treatment/retreatment, number of outpatient visits, duration of intensive treatment, presence of extrapulmonary tuberculosis, and presence of chronic aspergillosis. Based on a reexamination of chest CT scans to evaluate lung cavity absorption after completion of treatment, patients were categorized into the cavity closure group or cavity persistence group. Multivariate logistic regression analysis was conducted to identify factors influencing cavity persistence, and a forest plot was generated. Among the 218 rifampicin-sensitive pulmonary tuberculosis patients, 55 (25.23%) had persistent pulmonary cavities. Multivariate logistic regression analysis revealed that smoking (OR = 2.209, 95% CI = 1.029-4.739, P = .042), diabetes (OR = 3.423, 95% CI = 1.602-7.315, P = .001), retreatment (OR = 5.286, 95% CI = 1.983-14.087, P < .001), and chronic pulmonary aspergillosis (OR = 5.684, 95% CI = 2.459-13.138, P < .001) were significant factors influencing the persistence of cavities (P < .05). Smoking, diabetes, retreatment of pulmonary tuberculosis, and chronic pulmonary aspergillosis are all factors that influence the persistence of cavities in patients with rifampicin-sensitive pulmonary tuberculosis who have completed treatment in outpatient clinics. Early intervention should be implemented in these cases.

摘要

本研究基于多元回归分析,探讨了完成门诊随访治疗的利福平敏感型肺结核患者空洞持续存在的影响因素。选取2022年1月至2023年10月在我院进行随访的218例有空洞的利福平敏感型肺结核患者作为研究对象。收集患者的一般资料,包括性别、年龄、居住地、吸烟状况、咯血症状、是否患有糖尿病、初治/复治、门诊就诊次数、强化治疗时长、是否合并肺外结核以及是否患有慢性曲霉病。根据治疗结束后胸部CT复查评估肺空洞吸收情况,将患者分为空洞闭合组和空洞持续存在组。进行多因素逻辑回归分析以确定影响空洞持续存在的因素,并绘制森林图。在218例利福平敏感型肺结核患者中,55例(25.23%)存在持续性肺空洞。多因素逻辑回归分析显示,吸烟(OR = 2.209,95%CI = 1.029 - 4.739,P = 0.042)、糖尿病(OR = 3.423,95%CI = 1.602 - 7.315,P = 0.001)、复治(OR = 5.286,95%CI = 1.983 - 14.087,P < 0.001)和慢性肺曲霉病(OR = 5.684,95%CI = 2.459 - 13.138,P < 0.001)是影响空洞持续存在的显著因素(P < 0.05)。吸烟、糖尿病、肺结核复治以及慢性肺曲霉病均是影响完成门诊治疗的利福平敏感型肺结核患者空洞持续存在的因素。对此类情况应实施早期干预。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b258/12212854/bce92881fe6d/medi-104-e43089-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b258/12212854/cc7629d79a75/medi-104-e43089-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b258/12212854/bce92881fe6d/medi-104-e43089-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b258/12212854/cc7629d79a75/medi-104-e43089-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b258/12212854/bce92881fe6d/medi-104-e43089-g002.jpg

相似文献

1
Exploring the influencing factors of cavities persist in rifampicin-sensitive pulmonary tuberculosis patients who have completed outpatient treatment based on logistic regression forest plot.基于逻辑回归森林图探索完成门诊治疗的利福平敏感型肺结核患者空洞持续存在的影响因素。
Medicine (Baltimore). 2025 Jun 27;104(26):e43089. doi: 10.1097/MD.0000000000043089.
2
Treatment outcomes in cavitary multidrug-resistant/rifampicin-resistant tuberculosis and risk factors for cavity closure: a retrospective cohort study in Southwest China.空洞型耐多药/利福平耐药结核病的治疗结局及空洞闭合的危险因素:中国西南地区的一项回顾性队列研究
Sci Rep. 2025 Jul 1;15(1):21302. doi: 10.1038/s41598-025-06080-z.
3
Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children.Xpert MTB/RIF Ultra assay 用于儿童结核病和利福平耐药检测。
Cochrane Database Syst Rev. 2022 Sep 6;9(9):CD013359. doi: 10.1002/14651858.CD013359.pub3.
4
Xpert MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance.用于肺外结核病和利福平耐药性的Xpert MTB/RIF检测
Cochrane Database Syst Rev. 2018 Aug 27;8(8):CD012768. doi: 10.1002/14651858.CD012768.pub2.
5
Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin.Xpert MTB/XDR 检测系统用于检测肺结核病及异烟肼、氟喹诺酮类、乙胺丁醇和阿米卡星耐药性。
Cochrane Database Syst Rev. 2022 May 18;5(5):CD014841. doi: 10.1002/14651858.CD014841.pub2.
6
Effects of conditional cash transfers and pre-test and post-test tuberculosis counselling on patient outcomes and loss to follow-up across the continuum of care in South Africa: a randomised controlled trial.条件现金转移支付以及结核病前后测咨询对南非连续护理过程中患者治疗结果及失访情况的影响:一项随机对照试验
Lancet Infect Dis. 2025 Jul;25(7):764-774. doi: 10.1016/S1473-3099(24)00816-8. Epub 2025 Feb 6.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Six-month therapy for abdominal tuberculosis.腹部结核的六个月治疗
Cochrane Database Syst Rev. 2016 Nov 1;11(11):CD012163. doi: 10.1002/14651858.CD012163.pub2.
9
Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views.快速分子检测结核分枝杆菌和结核分枝杆菌耐药性:受检者和提供者观点的定性证据综合评价。
Cochrane Database Syst Rev. 2022 Apr 26;4(4):CD014877. doi: 10.1002/14651858.CD014877.pub2.
10
Thoracic imaging tests for the diagnosis of COVID-19.用于 COVID-19 诊断的胸部影像学检查。
Cochrane Database Syst Rev. 2022 May 16;5(5):CD013639. doi: 10.1002/14651858.CD013639.pub5.

本文引用的文献

1
Recurrent Pulmonary Tuberculosis in China, 2005 to 2021.中国 2005 至 2021 年复发性肺结核情况。
JAMA Netw Open. 2024 Aug 1;7(8):e2427266. doi: 10.1001/jamanetworkopen.2024.27266.
2
Chronic pulmonary aspergillosis incidence in newly detected pulmonary tuberculosis cases during follow-up.随访中新发现肺结核病例中慢性肺曲霉病的发病率。
Mycoses. 2024 May;67(5):e13747. doi: 10.1111/myc.13747.
3
Chronic Pulmonary Aspergillosis as a Considerable Complication in Post-Tuberculosis Lung Disease.慢性肺曲霉病作为肺结核后肺部疾病的一种严重并发症。
Semin Respir Crit Care Med. 2024 Feb;45(1):102-113. doi: 10.1055/s-0043-1776913. Epub 2024 Jan 9.
4
Chronic Pulmonary Aspergillosis: Clinical Presentation and Management.慢性肺曲霉病:临床表现与管理。
Semin Respir Crit Care Med. 2024 Feb;45(1):88-101. doi: 10.1055/s-0043-1776914. Epub 2023 Dec 28.
5
Impact of diabetes itself and glycemic control status on tuberculosis.糖尿病本身及其血糖控制状况对结核病的影响。
Front Endocrinol (Lausanne). 2023 Nov 8;14:1250001. doi: 10.3389/fendo.2023.1250001. eCollection 2023.
6
Tuberculosis reinfection and relapse in eastern China: a prospective study using whole-genome sequencing.中国东部地区结核分枝杆菌再感染和复发的前瞻性研究:全基因组测序的应用。
Clin Microbiol Infect. 2022 Nov;28(11):1458-1464. doi: 10.1016/j.cmi.2022.05.019. Epub 2022 Jun 11.
7
Clinical features and risk factors of pulmonary tuberculosis complicated with pulmonary aspergillosis.肺结核合并肺曲霉病的临床特征及危险因素。
Eur Rev Med Pharmacol Sci. 2022 Apr;26(8):2692-2701. doi: 10.26355/eurrev_202204_28599.
8
Concomitant Pulmonary Tuberculosis and Invasive Aspergillosis Infection in an Immunocompetent Host.免疫功能正常宿主合并肺结核和侵袭性曲霉感染
Eur J Case Rep Intern Med. 2022 Mar 21;9(3):003249. doi: 10.12890/2022_003249. eCollection 2022.
9
Clinical Factors Associated with Cavitary Tuberculosis and Its Treatment Outcomes.与空洞型肺结核及其治疗结果相关的临床因素。
J Pers Med. 2021 Oct 25;11(11):1081. doi: 10.3390/jpm11111081.
10
Transbronchial tuberculosis cavity plugging therapy for pulmonary tuberculosis.经支气管镜结核空洞封堵治疗肺结核。
J Int Med Res. 2021 Aug;49(8):3000605211035889. doi: 10.1177/03000605211035889.